Itau Unibanco Holding S.A. Invitae Corp Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.71 - $3.61 $1,740 - $3,674	-1,018 Reduced 11.11%	8,141 $15,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $17,402 - $79,042	9,159 New	9,159 $23,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $1,444 - $6,108	-678 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $352 - $688	-24 Reduced 3.42%	678 $11,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $243 - $336	-10 Reduced 1.4%	702 $20,000
Q2 2021 Aug 17, 2021	BUY	$26.09 - $40.4 $18,576 - $28,764	712 New	712 $24,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.